rs77738279

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001080463.2(DYNC2H1):​c.2454G>A​(p.Glu818Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0442 in 1,612,950 control chromosomes in the GnomAD database, including 1,778 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.033 ( 107 hom., cov: 32)
Exomes 𝑓: 0.045 ( 1671 hom. )

Consequence

DYNC2H1
NM_001080463.2 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.130

Publications

8 publications found
Variant links:
Genes affected
DYNC2H1 (HGNC:2962): (dynein cytoplasmic 2 heavy chain 1) This gene encodes a large cytoplasmic dynein protein that is involved in retrograde transport in the cilium and has a role in intraflagellar transport, a process required for ciliary/flagellar assembly. Mutations in this gene cause a heterogeneous spectrum of conditions related to altered primary cilium function and often involve polydactyly, abnormal skeletogenesis, and polycystic kidneys. Alternative splicing results in multiple transcript variants encoding distinct proteins. [provided by RefSeq, Jan 2010]
DYNC2H1 Gene-Disease associations (from GenCC):
  • asphyxiating thoracic dystrophy 3
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet, Ambry Genetics
  • Jeune syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • short rib-polydactyly syndrome, Majewski type
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • short rib-polydactyly syndrome, Verma-Naumoff type
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BP6
Variant 11-103135828-G-A is Benign according to our data. Variant chr11-103135828-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 302018.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.13 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0633 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DYNC2H1NM_001080463.2 linkc.2454G>A p.Glu818Glu synonymous_variant Exon 17 of 90 ENST00000650373.2 NP_001073932.1
DYNC2H1NM_001377.3 linkc.2454G>A p.Glu818Glu synonymous_variant Exon 17 of 89 ENST00000375735.7 NP_001368.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DYNC2H1ENST00000650373.2 linkc.2454G>A p.Glu818Glu synonymous_variant Exon 17 of 90 NM_001080463.2 ENSP00000497174.1
DYNC2H1ENST00000375735.7 linkc.2454G>A p.Glu818Glu synonymous_variant Exon 17 of 89 1 NM_001377.3 ENSP00000364887.2

Frequencies

GnomAD3 genomes
AF:
0.0334
AC:
5087
AN:
152094
Hom.:
107
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00775
Gnomad AMI
AF:
0.0725
Gnomad AMR
AF:
0.0286
Gnomad ASJ
AF:
0.0320
Gnomad EAS
AF:
0.0644
Gnomad SAS
AF:
0.0694
Gnomad FIN
AF:
0.0359
Gnomad MID
AF:
0.0380
Gnomad NFE
AF:
0.0445
Gnomad OTH
AF:
0.0322
GnomAD2 exomes
AF:
0.0412
AC:
10208
AN:
247832
AF XY:
0.0442
show subpopulations
Gnomad AFR exome
AF:
0.00648
Gnomad AMR exome
AF:
0.0204
Gnomad ASJ exome
AF:
0.0336
Gnomad EAS exome
AF:
0.0614
Gnomad FIN exome
AF:
0.0367
Gnomad NFE exome
AF:
0.0430
Gnomad OTH exome
AF:
0.0419
GnomAD4 exome
AF:
0.0453
AC:
66183
AN:
1460738
Hom.:
1671
Cov.:
31
AF XY:
0.0465
AC XY:
33772
AN XY:
726554
show subpopulations
African (AFR)
AF:
0.00619
AC:
207
AN:
33462
American (AMR)
AF:
0.0208
AC:
925
AN:
44560
Ashkenazi Jewish (ASJ)
AF:
0.0337
AC:
881
AN:
26116
East Asian (EAS)
AF:
0.0773
AC:
3063
AN:
39644
South Asian (SAS)
AF:
0.0663
AC:
5712
AN:
86110
European-Finnish (FIN)
AF:
0.0366
AC:
1951
AN:
53310
Middle Eastern (MID)
AF:
0.0342
AC:
197
AN:
5762
European-Non Finnish (NFE)
AF:
0.0456
AC:
50665
AN:
1111450
Other (OTH)
AF:
0.0428
AC:
2582
AN:
60324
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
3244
6488
9731
12975
16219
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1938
3876
5814
7752
9690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0334
AC:
5087
AN:
152212
Hom.:
107
Cov.:
32
AF XY:
0.0335
AC XY:
2494
AN XY:
74422
show subpopulations
African (AFR)
AF:
0.00773
AC:
321
AN:
41550
American (AMR)
AF:
0.0285
AC:
436
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.0320
AC:
111
AN:
3472
East Asian (EAS)
AF:
0.0645
AC:
334
AN:
5176
South Asian (SAS)
AF:
0.0695
AC:
334
AN:
4808
European-Finnish (FIN)
AF:
0.0359
AC:
381
AN:
10606
Middle Eastern (MID)
AF:
0.0408
AC:
12
AN:
294
European-Non Finnish (NFE)
AF:
0.0445
AC:
3025
AN:
68016
Other (OTH)
AF:
0.0318
AC:
67
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
254
507
761
1014
1268
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
66
132
198
264
330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0383
Hom.:
87
Bravo
AF:
0.0308
Asia WGS
AF:
0.0600
AC:
208
AN:
3476
EpiCase
AF:
0.0461
EpiControl
AF:
0.0485

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

May 19, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Jeune thoracic dystrophy Benign:2
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Asphyxiating thoracic dystrophy 3 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.75
CADD
Benign
3.3
DANN
Benign
0.49
PhyloP100
-0.13
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs77738279; hg19: chr11-103006557; COSMIC: COSV62089578; API